Results 261 to 270 of about 8,950,905 (317)

Single-cell analysis reveals immune remodeling of monocytes, NK cells, T cell exhaustion, and Galectin-9-associated depletion of gamma delta and mucosal-associated invariant T cells in Long COVID with ME/CFS. [PDF]

Front Immunol
Shahbaz S, Bozorgmehr N, Rahmati A, Abouda A, Syed H, Osman M, Elahi S.   +6 more
europepmc   +1 more source

Galectin-9 induces IL-1β production as a key inflammatory cytokine in the acute myeloid leukemia cell line (U937). [PDF]

Res Pharm Sci
Behranvand N, Nasri F, Moghaddam MV, Gholami MD, Safari E, Esmaeil N, Falak R.   +6 more
europepmc   +1 more source

Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia. [PDF]

Sci Adv
Wiggers CRM, Yüzügüldü B, Tadros NG, Heavican-Foral TB, Cho EY, Eisenbies ZC, Ozdemir M, Kulp SB, Chae YC, Gutierrez A, Lohr JG, Knoechel B.   +11 more
europepmc   +1 more source

Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade. [PDF]

Front Immunol
Hill CN, Maita G, Cabrolier C, Aros C, Vega-Letter AM, Gonzalez P, Kalergis AM, Luz-Crawford P, Owen GI.   +8 more
europepmc   +1 more source

Oral Presentation

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Galectin 9 rescues the inducibility of IL-10 expression in regulatory B cells of patients with food allergy. [PDF]

Sci Rep
Huang H, Li M, Song S, Feng S, Feng X, Liu Y, Yang P, Zheng P.   +7 more
europepmc   +1 more source

TIM-3/Galectin-9 Immune Axis in Colorectal Cancer in Relation to KRAS, NRAS, BRAF, PIK3CA, AKT1 Mutations, MSI Status, and the Cytokine Milieu. [PDF]

Int J Mol Sci
Ochman B, Kot A, Mielcarska S, Kula A, Dawidowicz M, Hudy D, Szrot M, Piecuch J, Waniczek D, Czuba Z, Świętochowska E.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Galectin-9 as a biomarker of disease severity.

Cellular Immunology, 2021
Galectin-9 (Gal-9) is a β-galactoside binding lectin known for its immunomodulatory role in various microbial infections. Gal-9 is expressed in all organ systems and localized in the nucleus, cell surface, cytoplasm and the extracellular matrix.
P. Moar, R. Tandon
semanticscholar   +3 more sources

Galectin-9 is a target for the treatment of cancer: A patent review.

International Journal of Biological Macromolecules, 2023
Galectins, which correspond to a group of proteins capable of recognizing and reversibly binding to β-galactoside carbohydrates, have been the subject of innovation and development of technological products.
Cássia Ferreira Rodrigues, Francisco Rubens Alves Dos Santos, Leonardo Andrade Abreu Amorim, André Luís Coelho da Silva, Lana Grasiela Alves Marques, B. A. M. Rocha   +5 more
semanticscholar   +3 more sources

Galectin-9 in Cancer Therapy

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 2013
Galectin-9 is a tandem-repeat type galectin with two carbohydrate-recognition domains, and it was first identified as an eosinophil chemoattractant and activation factor. Subsequent studies revealed that galectin-9, similar to other galectins, modulates a variety of biological functions including cell aggregation and adhesion, as well as apoptosis of ...
Shintaro, Fujihara, Hirohito, Mori, Hideki, Kobara, Kazi, Rafiq, Toshiro, Niki, Mitsuomi, Hirashima, Tsutomu, Masaki   +6 more
openaire   +2 more sources